Varmed Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.70 M
as on 31-12-2024
- Revenue 98.70%
(FY 2020)
- Profit -3.11%
(FY 2020)
- Ebitda 175.11%
(FY 2020)
- Net Worth 11.43%
(FY 2020)
- Total Assets 59.92%
(FY 2020)
About Varmed Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Bhoj Bajaj and Manju Bajaj serve as directors at the Company.
- CIN/LLPIN
U24304HR2018PTC072714
- Company No.
072714
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Varmed Pharma Private Limited offer?
Varmed Pharma Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Oil, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Hand Sanitizers & Personal Hygiene, Beauty Soap, Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Antihistamines.
Who are the key members and board of directors at Varmed Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhoj Bajaj  | Director | 23-Feb-2018 | Current |
| Manju Bajaj | Director | 14-Jul-2023 | Current |
Financial Performance of Varmed Pharma.
Varmed Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 98.7% increase. The company also saw a slight decrease in profitability, with a 3.11% decrease in profit. The company's net worth Soared by an impressive increase of 11.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Varmed Pharma?
Unlock access to Varmed Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Dec 2023 | ₹0.70 M | Open |
How Many Employees Work at Varmed Pharma?
Unlock and access historical data on people associated with Varmed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Varmed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Varmed Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
